Works about PROGRAMMED death-ligand 1

Results: 3775

Genomic and immunological profiling reveals novel prognostic biomarkers for limited-stage small cell lung cancer.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02925-1

By:

Li, Ye;
Ma, Xiaolong;
Wan, Zhiyi;
Bao, Pengfei;
Zhang, Enli;
Liu, Lihua;
Jiao, Shunchang;
Sun, Shengjie

Publication type:

Article

The clinicopathological significance and prognostic value of PD‐L1 in oral squamous cell carcinoma.

Published in:

Oral Diseases, 2025, v. 31, n. 3, p. 815, doi. 10.1111/odi.15096

By:

Li, Yizhan;
Ren, Wenhao;
Li, Shaoming;
Zheng, Jingjing;
Gu, Haiyan;
Gao, Ling;
Zhi, Keqian

Publication type:

Article

Diagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience.

Published in:

Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 4, p. 641, doi. 10.1177/10781552241252627

By:

Elghawy, Omar;
Patel, Reema;
Barsouk, Adam;
Puthumana, Joe;
Xu, Jason;
Sussman, Jonathan;
Horton, Bethany;
Kaur, Varinder

Publication type:

Article

The expression of programmed death-ligand 1 and its association with histopathological grade, stage of disease, and occurrence of metastasis in breast cancer.

Published in:

Breast Disease, 2021, v. 40, p. S71, doi. 10.3233/BD-219010

By:

Pranoto, Agung Sindu;
Haryasena, Haryasena;
Prihantono, Prihantono;
Rahman, Septiman;
Sampepajung, Daniel;
Indra, Indra;
Syamsu, Salman Ardy;
Sampepajung, Elridho;
Nelwan, Berti Julian;
Faruk, Muhammad

Publication type:

Article

PD-L1 expression in tumor lesions and soluble PD-L1 serum levels in patients with breast cancer: TNBC versus TPBC.

Published in:

Breast Disease, 2021, v. 40, n. 1, p. 43, doi. 10.3233/BD-201049

By:

Yazdanpanah, Parvaneh;
Alavianmehr, Ali;
Ghaderi, Abbas;
Monabati, Ahmad;
Montazer, Mehdi;
Tahmasbi, Kamran;
Farjadian, Shirin

Publication type:

Article

Biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and the immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell carcinoma.

Published in:

American Journal of Clinical Pathology, 2025, v. 163, n. 6, p. 898, doi. 10.1093/ajcp/aqaf022

By:

Tekin, Burak;
Cheville, John C;
Lucien, Fabrice;
McCarthy, Michael;
Dong, Haidong;
Kopp, Karla J;
Torell, Nate R;
Lavoie, Roxane R;
Farrell, Ava;
Jaszewski, Brandy L;
Smith, Carin Y;
Jenkins, Sarah M;
Dasari, Surendra;
Menon, Santosh;
Whaley, Rumeal D;
Boorjian, Stephen A;
Pagliaro, Lance C;
Erickson, Lori A;
Guo, Ruifeng;
Gupta, Sounak

Publication type:

Article

Editorial: Overcoming therapeutic resistance in head and neck squamous cell carcinoma.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1611819

By:

Roy, Souvick;
Sen, Prakriti;
Kar, Madhabananda;
Banerjee, Birendranath

Publication type:

Article

First-line treatment options for PD-L1-negative lung adenocarcinoma: a real-world analysis.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1533048

By:

Chen, Lijuan;
Liu, Jie;
Lu, Junfeng;
Hu, Xiufeng;
An, Erjing;
Zhao, Yanqiu

Publication type:

Article

Programmed cell death-ligand 1 expression in correlation with human papillomavirus status in cervical cancer: A 1-year retrospective study.

Published in:

Journal of Clinical & Scientific Research, 2025, v. 14, n. 1, p. 27, doi. 10.4103/jcsr.jcsr_24_24

By:

Konkay, Kaumudi;
Chaganti, Padmavathi Devi;
Medidi, Radhika;
Varghese, Ann Mary;
Karri, Maruthi Devi

Publication type:

Article

Decoding the molecular landscape: HER2 and PD-L1 in advanced gastric cancer.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1567308

By:

Yao, Jun;
Sun, Qiang;
Wu, Han;
Zhao, Xiaokai;
Yang, Pengmin;
Wang, Xiaozhi;
Wang, Xintao;
Gu, Meiping;
Li, Jieyi;
Zheng, Yuansi;
Gong, Ziying;
Zhang, Daoyun;
Wang, Weijun

Publication type:

Article

Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1553882

By:

Ma, Hongfang;
Zhang, Shasha;
Jiao, Pengqing;
Ding, Haixia;
Wang, Fujun;
Zhao, Yue;
Wu, Jianhua;
Guo, Zhanjun

Publication type:

Article

The landscape and clinical impact of tumor-associated macrophages and PD-L1 in primary breast cancers and their brain metastases.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1598293

By:

Zimmer, Yannik Nicola;
Hanke, Benjamin;
Neyazi, Belal;
Rashidi, Ali;
Schaufler, Anna;
Dumitru, Claudia Alexandra;
Ignatov, Atanas;
Mawrin, Christian;
Sandalcioglu, I. Erol;
Stein, Klaus-Peter

Publication type:

Article

The efficacy and safety of regorafenib/fruquintinib combined with PD-1/PD-L1 for metastatic colorectal cancer: a meta-analysis based on single-arm studies.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1579293

By:

Yang, Fan;
Mao, Ying;
Huang, Hanyu;
Luo, Wen;
Liu, Li;
Chen, Wenzhi

Publication type:

Article

Breaking barriers: exploring blood–brain barrier crossing mechanisms with nanomedicine for effective glioma treatment.

Published in:

3 Biotech, 2025, v. 15, n. 7, p. 1, doi. 10.1007/s13205-025-04378-3

By:

Ali, Syed Hammad;
Ali, Hiba;
Shafi, Midhat;
Malik, Abdul

Publication type:

Article

Effect of Early Tumor Shrinkage and Depth of Response on the Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization and Lenvatinib plus PD-1 Inhibitors.

Published in:

Oncology Research & Treatment, 2025, v. 48, n. 6, p. 360, doi. 10.1159/000545210

By:

Zhang, Xiaobing;
Shen, Zhemin;
Qu, Shuping;
Pan, Hongyu;
Chen, Yalin;
Wu, Dong

Publication type:

Article

Early growth response 1 as a key regulator of PD-L1 expression and immune evasion in extranodal NK/T-cell lymphoma.

Published in:

Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01313-w

By:

Lee, Ji Yun;
Kim, Kui-Jin;
Park, Woochan;
Seo, Jeongmin;
Kang, Minsu;
Jung, Eun Hee;
Kim, Sang-A;
Suh, Koung Jin;
Kim, Ji-Won;
Kim, Se Hyun;
Lee, Jeong-Ok;
Kim, Jin Won;
Kim, Yu Jung;
Lee, Keun-Wook;
Kim, Jee Hyun;
Bang, Soo-Mee;
Kim, Tae Min;
Paik, Jin Ho

Publication type:

Article

Bibliometric analysis of global research on PD-L1/PD-1 pathway and neurodegenerative diseases over the last two decades (2004–2023).

Published in:

Frontiers in Aging Neuroscience, 2025, p. 1, doi. 10.3389/fnagi.2025.1570428

By:

Wu, Jialin;
Zhang, Chaojin;
Cao, Qiang;
Xuan, Wei;
Huai, Xiaorong;
Zhou, Jie;
Tian, Jie

Publication type:

Article

Prediction of immunotherapy response in nasopharyngeal carcinoma: a comparative study using MRI-based radiomics signature and programmed cell death ligand 1 expression score.

Published in:

European Radiology, 2025, v. 35, n. 7, p. 4403, doi. 10.1007/s00330-025-11350-5

By:

Mai, Hui;
Li, Li;
Xin, Xin;
Jiang, Zhike;
Tang, Yongfang;
Huang, Jie;
Lei, Yanxing;
Chen, Lianzhi;
Dong, Tianfa;
Zhong, Xi

Publication type:

Article

The Immune Microenvironment in Prostate Cancer: A Comprehensive Review.

Published in:

Oncology, 2025, v. 103, n. 6, p. 521, doi. 10.1159/000541881

By:

Novysedlak, Rene;
Guney, Miray;
Al Khouri, Majd;
Bartolini, Robin;
Koumbas Foley, Lily;
Benesova, Iva;
Ozaniak, Andrej;
Novak, Vojtech;
Vesely, Stepan;
Pacas, Pavel;
Buchler, Tomas;
Ozaniak Strizova, Zuzana

Publication type:

Article

Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.

Published in:

Oncology, 2025, v. 103, n. 6, p. 490, doi. 10.1159/000541250

By:

LaPelusa, Michael;
Chamseddine, Shadi;
Tran Cao, Hop Sanderson;
Xiao, Lianchun;
Hasanov, Elshad;
Bhosale, Priya;
Amin, Hesham M.;
Mohamed, Yehia I.;
Gok Yavuz, Betul;
Sakr, Yara;
Xu, Li;
Hu, Ian;
Lee, Sunyoung S.;
Sakamuri, Divya;
Jindal, Sonali;
Nguyen, Van;
Curran, Michael A.;
Sun, Ryan;
Rashid, Asif;
Duda, Dan Gabriel

Publication type:

Article

Myomedin variants developed for in vitro PD-L1 diagnostics in tissue samples of non-small cell lung carcinoma patients.

Published in:

Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06699-6

By:

Petroková, Hana;
Mierzwicka, Joanna Maria;
Chakraborty, Prosenjit;
Rašková Kafková, Leona;
Vaculová, Jana;
Škarda, Jozef;
Fischer, Ondřej;
Kosztyu, Petr;
Kuchař, Milan;
Raška, Milan;
Malý, Petr

Publication type:

Article

Sex-determining region Y-Box 4 promotes the progression of advanced hepatocellular carcinoma and enhances regulatory T-cell infiltration and immune suppression.

Published in:

CytoJournal, 2025, v. 22, p. 1, doi. 10.25259/Cytojournal_27_2025

By:

Jing, Yingxia;
Wu, Yunlong

Publication type:

Article

Biomarker-Specific Survival and Medication Cost for Patients With Non–Small Cell Lung Cancer.

Published in:

JAMA Network Open, 2025, v. 8, n. 6, p. e2514519, doi. 10.1001/jamanetworkopen.2025.14519

By:

Tan, Juanyi;
Yang, Szu-Chun;
Dinan, Michaela A.;
Chiang, Anne C.;
Gross, Cary P.;
Wang, Shi-Yi

Publication type:

Article

Immunohistochemistry for Skin Cancers: New Insights into Diagnosis and Treatment of Melanoma.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1769, doi. 10.3390/cancers17111769

By:

Voiculescu, Vlad-Mihai;
Popescu, Alina-Ioana;
Costache, Mariana

Publication type:

Article

Skeletal Muscle Density as a Predictive Marker for Pathologic Complete Response in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemoimmunotherapy.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1768, doi. 10.3390/cancers17111768

By:

Mun, Han Song;
Kim, Sung Hun;
Lee, Jieun;
Park, Se Jun;
Lee, Ahwon;
Kang, Jun;
Park, Woo-Chan;
Bae, Soo Youn;
Choi, Byung Ok;
Hong, Ji Hyun;
Oh, Soon Nam;
Shin, Kabsoo

Publication type:

Article

Regulatory Mechanisms and Therapeutic Targeting of PD-L1 Trafficking and Stability in Cancer Immunotherapy.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1747, doi. 10.3390/cancers17111747

By:

Mani, Muralidharan;
Park, Jeong Woo;
Martin, Thomas F. J.

Publication type:

Article

Pro-Resolving Macrophage-Induced IL-35 + but Not TGF-β1 + Regulatory B Cell Activation Requires the PD-L1/PD-1 Pathway.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 11, p. 5332, doi. 10.3390/ijms26115332

By:

Cao, Guoqin;
Memida, Takumi;
Huang, Shengyuan;
Dalir Abdolahinia, Elaheh;
Ruiz, Sunniva;
Hassantash, Sahar;
Ari, Jayant;
Shindo, Satoru;
Lin, Jiang;
Kawai, Toshihisa;
Han, Xiaozhe

Publication type:

Article

Case report: a R0 resection successfully induced by T-DXd plus PD-1 inhibitor regimen in a primary unresectable stage IIIB NSCLC with ERBB2-mutation.

Published in:

2025

By:

Zhang, Ruijie;
Cheng, Sida;
Sun, Kunkun;
Zhang, Lihong;
Yan, Xiang;
Yang, Fan

Publication type:

Case Study

Immunotherapy Applications in Urology.

Published in:

Journal of Urological Surgery, 2025, v. 12, n. 2, p. 1, doi. 10.4274/jus.galenos.2025.2024-11-9

By:

Şenoğlu, Yusuf;
Şahin, Bahadır

Publication type:

Article

Chromophobe renal cell carcinoma with sarcomatoid change: A case report.

Published in:

Oncology Letters, 2025, v. 30, n. 1, p. N.PAG, doi. 10.3892/ol.2025.15117

By:

Ahn, Ae Ri;
Noh, Sang Jae;
Jeong, Young Bum;
Kim, Kyoung Min

Publication type:

Article

Primary pulmonary malignant melanoma with H3K27Me3 loss: A case report.

Published in:

2025

By:

Li, Houqiang;
Zheng, Lanqing;
Yu, Xunbin;
Chen, Linfeng;
Lv, Shanshan;
Chen, Xin

Publication type:

Case Study

Constitutional Mismatch Repair Deficiency, the Most Aggressive Cancer Predisposition Syndrome : Clinical Presentation, Surveillance, and Management.

Published in:

Journal of Korean Neurosurgical Society, 2025, v. 68, n. 3, p. 294, doi. 10.3340/jkns.2025.0024

By:

Kang, Eungu;
Suh, Jin Kyung;
Kim, Sang-Dae

Publication type:

Article

Efficacy and safety of autologous CIK cell therapy plus Toripalimab with or without chemotherapy in advanced NSCLC: A phase II study.

Published in:

International Journal of Cancer, 2025, v. 157, n. 3, p. 549, doi. 10.1002/ijc.35422

By:

Zhong, Runbo;
Chu, Tianqing;
Xiong, Liwen;
Shi, Chunlei;
Zhang, Wei;
Zhang, Xueyan;
Yang, Xiaohua;
Lian, Yuqing;
Zhang, Mengqi;
Zhong, Hua;
Han, Baohui

Publication type:

Article

Neoadjuvant therapy-induced immune dynamics and myeloid-associated resistance in advanced head and neck cancer.

Published in:

NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00954-1

By:

Kimura, Alisa;
Mitsuda, Junichi;
Yoshimura, Kanako;
Saburi, Sumiyo;
Murakami, Nanako;
Sakurai, Nana;
Yoshizawa, Koichi;
Morimoto, Hiroki;
Mukudai, Shigeyuki;
Nagao, Hikaru;
Ogi, Hiroshi;
Shibata, Saya;
Miyagawa-Hayashino, Aya;
Konishi, Eiichi;
Itoh, Kyoko;
Hirano, Shigeru;
Tsujikawa, Takahiro

Publication type:

Article

LMNB2-mediated high PD-L1 transcription triggers the immune escape of hepatocellular carcinoma.

Published in:

Cell Death Discovery, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41420-025-02540-7

By:

Li, Yuxuan;
Zhu, Jie;
Zhai, Fengguang;
Ge, Yidong;
Zhan, Ziqing;
Wang, Shuyan;
Kong, Lili;
Zhao, Jianan;
Hu, Lecheng;
Wang, Siyuan;
Shi, Jiaxin;
Mao, Jianing;
Yu, Zongdong;
Wang, Haoyun;
Jin, Jiabei;
Zhao, Mengxiang;
Li, Hong;
Jin, Xiaofeng

Publication type:

Article

Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients Diagnosed With Locally Advanced/Metastatic Urothelial Carcinoma Prior to Receiving Enfortumab Vedotin: A Real‐World Evidence Study.

Published in:

International Journal of Urology, 2025, v. 32, n. 6, p. 650, doi. 10.1111/iju.70023

By:

Morgans, Alicia K.;
Mucha, Lisa;
Quicquaro, Christina;
Shih, Vanessa;
Xie, Bin;
Young, Christopher;
Yang, Hongbo;
Liu, Qing;
Greatsinger, Alexandra;
Lax, Angela

Publication type:

Article

Small Cell Lung Cancer: A Review.

Published in:

JAMA: Journal of the American Medical Association, 2025, v. 333, n. 21, p. 1906, doi. 10.1001/jama.2025.0560

By:

Kim, So Yeon;
Park, Henry S.;
Chiang, Anne C.

Publication type:

Article

Cytotoxic T Lymphocyte Density and PD‐L1 Expression Predict the Response to Anti‐PD1 Therapy in Recurrent Oral Squamous Cell Carcinoma.

Published in:

Microbiology & Immunology, 2025, v. 69, n. 6, p. 350, doi. 10.1111/1348-0421.13220

By:

Yamashita, Mayuko;
Yano, Hiromu;
Komohara, Yoshihiro;
Yamada, Rin;
Fujiwara, Yukio;
Hirayama, Masatoshi;
Seki, Yuki;
Yoshida, Ryoji;
Nakayama, Hideki

Publication type:

Article

Lysine‐specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti‐programmed death 1 therapy in liver cancer.

Published in:

Clinical & Translational Medicine, 2025, v. 15, n. 5, p. 1, doi. 10.1002/ctm2.70335

By:

Liang, Chen;
Ye, Mu;
Yu, Lei;
Zhang, Peng‐Fei;
Guo, Xiao‐Jun;
Meng, Xian‐Long;
Zeng, Hai‐Ying;
Hu, Shu‐Yang;
Zhang, Dao‐Han;
Sun, Qi‐Man;
Shen, Ying‐Hao;
Cai, Jia‐Bin;
Li, Shuang‐Qi;
Chen, Zhen;
Shi, Ying‐Hong;
Ke, Ai‐Wu;
Shi, Yujiang G.;
Zhou, Jian;
Fan, Jia;
Wu, Fei‐Zhen

Publication type:

Article

Circulating PD-1<sup>hi</sup> CXCR5– and CXCR5+ CD4 T cells are elevated in patients with newly diagnosed giant cell arteritis, and predict relapse.

Published in:

Rheumatology, 2025, v. 64, n. 6, p. 3996, doi. 10.1093/rheumatology/keaf001

By:

Monjo-Henry, Irene;
Nieto-Carvalhal, Beatriz;
Uyaguari, Mariela;
García-Carazo, Sara;
Balsa, Alejandro;
Miguel, Eugenio de;
Miranda-Carús, María-Eugenia

Publication type:

Article

CD73 promotes the maturation of murine NK cells and their survival in the tumor microenvironment.

Published in:

Journal of Leukocyte Biology, 2025, v. 117, n. 5, p. 1, doi. 10.1093/jleuko/qiaf011

By:

Parra-Tello, Brian;
García-Gómez, Moira;
Rekus-Polanska, Eva;
Malgue, Felipe;
Charlín, Sebastián;
Hernández-Oliveras, Andrés;
Reyes-Alvarez, Javiera;
Rosemblatt, Mario;
Lundqvist, Andreas;
Lladser, Alvaro;
Bono, María Rosa;
Sauma, Daniela

Publication type:

Article

PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-analysis.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1496611

By:

Song, Chao;
Qiu, Yuan;
Fan, Huan;
Han, Yongqing

Publication type:

Article

PD-1高表达细菌质膜囊泡的构建及对小鼠肺癌移植瘤组织的靶向性评估.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 3, p. 239, doi. 10.3872/j.issn.1007-385x.2025.03.002

By:

徐秀杰;
张静云;
范峻晨;
蒋灵馨;
张娜;
郑猛超;
龙雨飞;
高贵花;
颜涛玲;
兰天舒

Publication type:

Article

Influence of programmed death ligand 1 (PD-L1) knockout on gut microbiota in experimental autoimmune uveitis.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1600673

By:

Gu, Junxiang;
Ma, Yixian;
Chang, Qing;
Chen, Ling

Publication type:

Article

Efficacy of neoadjuvant, adjuvant, and perioperative immunotherapy in non-small cell lung cancer across different PD-L1 expression levels: a systematic review and meta-analysis.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1569864

By:

Zhang, Zhenlong;
Lin, Yuchen;
Chen, Shuchen

Publication type:

Article

B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8<sup>+</sup> T-cell exhaustion in non-small cell lung cancer.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1553042

By:

Zhang, Yang;
Yang, Yang;
Zeng, Yuanyuan;
Qu, Qiuxia;
Shen, Dan;
Mu, Chuanyong;
Lei, Wei;
Su, Meiqin;
Mao, Jingyu;
Gao, Lirong;
Liu, Zeyi;
Chen, Cheng;
Huang, Jian-an

Publication type:

Article

Comparative performance of PD‐L1 scoring by pathologists and AI algorithms.

Published in:

Histopathology, 2025, v. 87, n. 1, p. 90, doi. 10.1111/his.15432

By:

Plass, Markus;
Olteanu, Gheorghe‐Emilian;
Dacic, Sanja;
Kern, Izidor;
Zacharias, Martin;
Popper, Helmut;
Fukuoka, Junya;
Ishijima, Sosuke;
Kargl, Michaela;
Murauer, Christoph;
Kalson, Lipika;
Brcic, Luka

Publication type:

Article

Efficacy of radiolabelled PD-L1-targeted nanobody in predicting and evaluating the combined immunotherapy and chemotherapy for resectable non-small cell lung cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 7, p. 2343, doi. 10.1007/s00259-025-07115-3

By:

Zhou, Xin;
Yan, Shi;
Ma, Xiaopan;
Zhu, Hua;
Liu, Bing;
Yang, Xin;
Jia, Bing;
Yang, Zhi;
Wu, Nan;
Li, Nan

Publication type:

Article

Malignant Common Bile Duct Stricture Secondary to Metastatic Squamous Cell Carcinoma of the Cervix.

Published in:

ACG Case Reports Journal, 2025, v. 12, n. 5, p. 1, doi. 10.14309/crj.0000000000001691

By:

Jaber, Hasan;
Phox, Meagan;
Al Souky, Nader;
Kadado, Kevin;
Mohamed, Wael;
Rowe, Kyle

Publication type:

Article

Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy.

Published in:

Cells (2073-4409), 2025, v. 14, n. 10, p. 741, doi. 10.3390/cells14100741

By:

Saeed, Abdullah Farhan

Publication type:

Article